Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C (Q33672561)

28 July 2017

title

Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

23 June 2024

1 reference

Masao Honda

1 reference

28 July 2017

Mikiko Nakamura

1 reference

28 July 2017

Makoto Tateno

1 reference

28 July 2017

Akito Sakai

1 reference

28 July 2017

Tetsuro Shimakami

1 reference

28 July 2017

Takayoshi Shirasaki

1 reference

28 July 2017

Tatsuya Yamashita

1 reference

28 July 2017

Kuniaki Arai

1 reference

28 July 2017

Taro Yamashita

1 reference

28 July 2017

Yoshio Sakai

1 reference

28 July 2017

Shuichi Kaneko

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20739080

23 June 2024

publication date

15 July 2010

1 reference

full work available at URL

28 July 2017

https://api.elsevier.com/content/article/PII:S0168827810006100?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

https://api.elsevier.com/content/article/PII:S0168827810006100?httpAccept=text/plain

23 June 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

23 June 2024

published in

Journal of Hepatology

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

817-826

1 reference

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Gene expression and hepatitis C virus infection

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Rapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patients

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Interferon signaling and treatment outcome in chronic hepatitis C

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.04.036

23 June 2024

Identifiers

1 reference

release_zp464bsubrcwxbr4z5du2wvoou

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zp464bsubrcwxbr4z5du2wvoou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference